IRVINE, Calif., March 08, 2021 – HealthBanks Biotech (USA), Inc. (“HealthBanks” or the “Company”), a premium cell banking network, today announced that through its subsidiary, ImmuneCyte Inc. (“ImmuneCyte”), the Company has executed an acquisition agreement with...
IRVINE, Calif. (Dec. 15, 2020) – HealthBanks Biotech, Inc. (the “HealthBanks”), a technological leader in the stem cell banking industry, today introduced the first-of-its-kind, GMP-compliant immune cell banking service for future use in immunotherapies. In the fight...
HealthBanks Kicks Off Holiday Season Launch with $660 Introductory Pricing and a Price Match Guarantee Throughout the holiday season, expecting parents can take advantage of the industry’s best technology at the industry’s best price IRVINE, Calif., Dec. 8, 2020 –...
IRVINE, Calif., Nov 24, 2020 – HealthBanks Biotech, Inc. (the “HealthBanks”), a technological leader in stem cell the banking industry, announces today its change in cord blood banking brand name from Pacificord to HealthBanks. Founded in 2001, HealthBanks...
CAR T-cell Therapy: A Major Breakthrough in Cancer Treatment In modern medicine, the four pillars of cancer treatment have always been surgery, chemotherapy, radiation therapy and targeted therapy. Recently, a fifth pillar has emerged — immunotherapy. ...
